10-Q Filing

LifeMD, Inc. CIK: 948320 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001144204-13-061835`
Period End Date	20130930
Filing Date	20131114
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	immd-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 60 Cash Flow Statement 46 Stockholders Equity 10

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$33.50K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$163.18K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$98.93K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$46.65K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	29.41M	shares	Point-in-time
Trade accounts receivable	`AccountsReceivableNetCurrent`	$49.69K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	29.41M	shares	Point-in-time
Trade accounts receivable	`AccountsReceivableNetCurrent`	$11.31K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	29.41M	shares	Point-in-time
Inventory	`InventoryNet`	$120.05K	USD	Point-in-time
Inventory	`InventoryNet`	$63.38K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	29.41M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$212.00K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$178.01K	USD	Point-in-time
Furnishings and equipment	`PropertyPlantAndEquipmentNet`	$114.97K	USD	Point-in-time
Furnishings and equipment	`PropertyPlantAndEquipmentNet`	$157.70K	USD	Point-in-time
Total Assets	`Assets`	$369.69K	USD	Point-in-time
Total Assets	`Assets`	$292.97K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$207.28K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$187.10K	USD	Point-in-time
Advance payable	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Advance payable	`DueToRelatedPartiesCurrent`	$10.20K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$217.48K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$187.10K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$47.60K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$34.70K	USD	Point-in-time
Total Liabilities	`Liabilities`	$252.18K	USD	Point-in-time
Total Liabilities	`Liabilities`	$234.70K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 29,409,973 shares issued and outstanding at September 30, 2013	`CommonStockValue`	$294.10K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 29,409,973 shares issued and outstanding at September 30, 2013	`CommonStockValue`	$289.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.64M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.74M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-7.80M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-7.99M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$40.79K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$135.00K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$292.97K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$369.69K	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$94.68K	USD	1 Quarter
Sales	`Revenues`	$152.12K	USD	1 Quarter
Sales	`Revenues`	$647.84K	USD	3 Qtrs
Sales	`Revenues`	$558.22K	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$124.18K	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$53.85K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$17.48K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$190.78K	USD	3 Qtrs
Gross Profit	`GrossProfit`	$523.66K	USD	3 Qtrs
Gross Profit	`GrossProfit`	$367.44K	USD	3 Qtrs
Gross Profit	`GrossProfit`	$98.26K	USD	1 Quarter
Gross Profit	`GrossProfit`	$77.20K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$102.17K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$104.67K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$329.64K	USD	3 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$380.15K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$175.34K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$20.13K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$104.16K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$71.83K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$85.41K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$277.63K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$123.57K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$298.95K	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-168.67K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-163.64K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-415.18K	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-259.61K	USD	3 Qtrs
License Fee	`LicenseCosts`	$-50.00K	USD	3 Qtrs
License Fee	`LicenseCosts`	$-25.00K	USD	3 Qtrs
License Fee	`LicenseCosts`	-	USD	1 Quarter
License Fee	`LicenseCosts`	$-25.00K	USD	1 Quarter
Other income	`OtherIncome`	$6.16K	USD	3 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	-	USD	3 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Interest (expense)	`InterestExpense`	-	USD	3 Qtrs
Interest (expense)	`InterestExpense`	-	USD	1 Quarter
Interest (expense)	`InterestExpense`	-	USD	1 Quarter
Interest (expense)	`InterestExpense`	$3.37K	USD	3 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-163.64K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-143.67K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-209.61K	USD	3 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-387.38K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-196.71K	USD	3 Qtrs
Net (Loss)	`NetIncomeLoss`	$-139.37K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-159.34K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-374.49K	USD	3 Qtrs
Basic and diluted (loss) per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	3 Qtrs
Basic and diluted (loss) per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted (loss) per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted (loss) per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	3 Qtrs
Average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	28.89M	shares	1 Quarter
Average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29.41M	shares	1 Quarter
Average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	27.06M	shares	3 Qtrs
Average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29,194.50	shares	3 Qtrs

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net (Loss)	`NetIncomeLoss`	$-196.71K	USD	3 Qtrs
Net (Loss)	`NetIncomeLoss`	$-139.37K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-159.34K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-374.49K	USD	3 Qtrs
Depreciation	`Depreciation`	$42.73K	USD	3 Qtrs
Depreciation	`Depreciation`	$42.44K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$52.50K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	-	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$23.00K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$71.50K	USD	3 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$-119.00K	USD	3 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$42.94K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-38.38K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$56.67K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-21.86K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$10.06K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$20.19K	USD	3 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-112.48K	USD	3 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-165.47K	USD	3 Qtrs
Exercise of stock options	`DeferredTaxExpenseFromStockOptionsExercised`	-	USD	3 Qtrs
Exercise of stock options	`DeferredTaxExpenseFromStockOptionsExercised`	$50.00K	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$345.88K	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Notes and advance payable	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$10.20K	USD	3 Qtrs
Notes and advance payable	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$-50.73K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$295.15K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.20K	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$129.68K	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-52.28K	USD	3 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$33.50K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$163.18K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$98.93K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$46.65K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$33.50K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$163.18K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$98.93K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$46.65K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaid`	$3.37K	USD	3 Qtrs
Notes payable and other payables used to exercise options and warrants	`NotesPayableAndOtherPayablesUsedToExerciseOptionsAndWarrants`	-	USD	3 Qtrs
Notes payable and other payables used to exercise options and warrants	`NotesPayableAndOtherPayablesUsedToExerciseOptionsAndWarrants`	$311.44K	USD	3 Qtrs

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$40.79K	USD	Point-in-time
Balance	`StockholdersEquity`	$135.00K	USD	Point-in-time
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$50.00K	USD	3 Qtrs
Amortization of stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$52.50K	USD	3 Qtrs
Net (loss)	`NetIncomeLoss`	$-196.71K	USD	3 Qtrs
Net (loss)	`NetIncomeLoss`	$-139.37K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-159.34K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-374.49K	USD	3 Qtrs
Balance	`StockholdersEquity`	$40.79K	USD	Point-in-time
Balance	`StockholdersEquity`	$135.00K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.